NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $58,057,000 | +29.3% | 1,623,073 | -6.0% | 2.60% | +37.9% |
| Q3 2014 | $44,897,000 | -14.0% | 1,726,824 | +9.3% | 1.89% | -14.6% |
| Q2 2014 | $52,222,000 | +23.9% | 1,580,094 | +12.2% | 2.21% | +27.6% |
| Q1 2014 | $42,163,000 | -21.8% | 1,408,729 | -20.6% | 1.73% | -25.4% |
| Q4 2013 | $53,887,000 | -18.7% | 1,774,919 | -14.8% | 2.32% | -27.1% |
| Q3 2013 | $66,264,000 | +90.5% | 2,083,128 | -9.5% | 3.19% | +209.8% |
| Q2 2013 | $34,790,000 | – | 2,302,428 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 431,525 | $11,219,000 | 4.40% |
| Palo Alto Investors LP | 1,699,562 | $44,189,000 | 3.30% |
| FCG ADVISORS, LLC | 133,504 | $4,116,000 | 2.71% |
| SECTORAL ASSET MANAGEMENT INC | 1,726,824 | $44,897,000 | 1.89% |
| Rhenman & Partners Asset Management AB | 224,000 | $5,824,000 | 1.70% |
| BENDER ROBERT & ASSOCIATES | 75,090 | $1,952,000 | 1.36% |
| Penn Capital Management Company, LLC | 1,035,144 | $26,914,000 | 1.12% |
| NEXT CENTURY GROWTH INVESTORS LLC | 1,066,148 | $27,719,000 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 391,281 | $10,173,000 | 0.98% |
| SCHOLTZ & COMPANY, LLC | 31,990 | $832,000 | 0.82% |